PCV39 COST UTILITY ANALYSIS OF CLOPIDOGREL IN ADDITION TO STANDARD CARE FOR ST-ELEVATED MYOCARDIAL INFARCTION-THE UK PERSPECTIVE
Nov 1, 2007, 00:00 AM
10.1016/S1098-3015(10)65454-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)65454-X/fulltext
Section Title :
Section Order :
612
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65454-X&doi=10.1016/S1098-3015(10)65454-X